PartnershipMay 6, 2026, 10:23 AM
LanzaTech & BRIGHT Partner to Accelerate Carbon-to-Value Biofoundry Tech
AI Summary
LanzaTech Global, Inc. and BRIGHT, the Novo Nordisk Foundation Biotechnology Research Institute at DTU, have entered a multi-year agreement until April 2028. This partnership aims to accelerate the development of technologies that convert carbon emissions into valuable products. Key aspects include the design and installation of a next-generation C1 biofoundry at DTU, leveraging LanzaTech's synthetic biology expertise and BRIGHT's infrastructure. The initiative is set to establish Denmark and Europe as significant players in carbon-to-value biotechnology, fostering sustainable innovation.
Key Highlights
- LanzaTech and BRIGHT entered a multi-year agreement until April 2028.
- Partnership includes designing and installing a next-generation C1 biofoundry at DTU.
- The biofoundry will convert CO2, CO, and methane into fuels, chemicals, and materials.
- LanzaTech will provide a non-exclusive license for relevant IP and biofoundry workflows.
- The collaboration aims for faster strain development cycles and reduced innovation risk.
- It will integrate AI-driven design tools to accelerate the Design Build Test Learn loop.